97 related articles for article (PubMed ID: 2575337)
1. The management of 138 psoriatic arthritic patients.
Scarpa R; Pucino A; Iocco M; Sollazzo M; Biondi Oriente C; Oriente P
Acta Derm Venereol Suppl (Stockh); 1989; 146():199-200. PubMed ID: 2575337
[TBL] [Abstract][Full Text] [Related]
2. [Psoriatic arthritis].
Tanimoto K
Ryoikibetsu Shokogun Shirizu; 2000; (32):521. PubMed ID: 11212791
[No Abstract] [Full Text] [Related]
3. What is psoriatic arthritis and what are some of the symptoms and treatments?
Duke Med Health News; 2012 Mar; 18(3):8. PubMed ID: 22745981
[No Abstract] [Full Text] [Related]
4. Etanercept (Enbrel) -- an update.
Goffe B
Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
[TBL] [Abstract][Full Text] [Related]
5. Psoriatic arthritis.
Holdsworth J
Nurs Stand; 2003 Oct 15-21; 18(5):47-52; quiz 54-5. PubMed ID: 14603767
[TBL] [Abstract][Full Text] [Related]
6. Current concepts and new developments in the treatment of psoriatic arthritis.
Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
[TBL] [Abstract][Full Text] [Related]
7. Classification criteria for psoriatic arthritis: development of new criteria from a large international study.
Taylor W; Gladman D; Helliwell P; Marchesoni A; Mease P; Mielants H;
Arthritis Rheum; 2006 Aug; 54(8):2665-73. PubMed ID: 16871531
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriatic arthritis.
Williamson L; Dockerty JL; Dalbeth N
Rheumatology (Oxford); 2004 Jul; 43(7):938-9. PubMed ID: 15213344
[No Abstract] [Full Text] [Related]
9. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
11. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
[TBL] [Abstract][Full Text] [Related]
12. [An evaluation of the results of the long-term treatment of rheumatoid arthritis patients with gold salts, aminoquinoline preparations and nonsteroidal anti-inflammatory preparations].
Ivanova MM; Karateev DE; Shakirova MR; Smirnov AV
Ter Arkh; 1997; 69(5):27-32. PubMed ID: 9235650
[No Abstract] [Full Text] [Related]
13. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
Nash P; Clegg DO
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943
[TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
Goodemote P; Jamieson B; Hoffman R
J Fam Pract; 2007 Nov; 56(11):933-4, 937. PubMed ID: 17976342
[No Abstract] [Full Text] [Related]
15. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
[TBL] [Abstract][Full Text] [Related]
16. [Pneumonitis caused by gold salts in psoriatic arthritis: report of 2 cases].
Manero Ruiz FJ; Larraga Palacio R; Herrero Labarga I; Ferrer Peralta M
An Med Interna; 2002 May; 19(5):237-40. PubMed ID: 12107998
[TBL] [Abstract][Full Text] [Related]
17. Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.
Fournié B; Crognier L; Arnaud C; Zabraniecki L; Lascaux-Lefebvre V; Marc V; Ginesty E; Andrieu V; Dromer C; Fournié A
Rev Rhum Engl Ed; 1999 Oct; 66(10):446-56. PubMed ID: 10567972
[TBL] [Abstract][Full Text] [Related]
18. Established psoriatic arthritis: clinical aspects.
Helliwell PS
J Rheumatol Suppl; 2009 Aug; 83():21-3. PubMed ID: 19661532
[TBL] [Abstract][Full Text] [Related]
19. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
Strober BE; Clarke S
J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
[TBL] [Abstract][Full Text] [Related]
20. Six months open label trial of leflunomide in active ankylosing spondylitis.
Haibel H; Rudwaleit M; Braun J; Sieper J
Ann Rheum Dis; 2005 Jan; 64(1):124-6. PubMed ID: 15608310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
